| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |